Walgreens Boots Alliance (WBA)
(Delayed Data from NSDQ)
$8.91 USD
-0.17 (-1.87%)
Updated Oct 9, 2024 04:00 PM ET
After-Market: $8.91 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.91 USD
-0.17 (-1.87%)
Updated Oct 9, 2024 04:00 PM ET
After-Market: $8.91 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth F Momentum D VGM
Zacks News
Stock Market News For Mar 6, 2019
by Zacks Equity Research
Markets closed in the red on Tuesday as investors refrained from betting big due to lack of any additional factors which would boost stocks.
Walgreens Boots Rides on Retail Pharmacy USA, Strategic Deals
by Zacks Equity Research
Walgreens Boots' (WBA) Retail Pharmacy USA division benefits from comparable prescription growth and a strong retail prescription market.
The Zacks Analyst Blog Highlights: NextEra Energy, Walgreens Boots, Southern Company, Ameriprise Financial and Macy's
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NextEra Energy, Walgreens Boots, Southern Company, Ameriprise Financial and Macy's
Wall Street Takes Notice of These 4 Stocks - Should You?
by Tirthankar Chakraborty
With the market in a volatile state, Wall Street's top investors are sorting the most valuable stocks - should you follow?
Top Research Reports for NextEra Energy, Walgreens Boots & Southern Company
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including NextEra Energy (NEE), Walgreens Boots (WBA) and Southern Company (SO).
Stock Market News For Feb 22, 2019
by Zacks Equity Research
Wall Street closed sharply lower on Thursday as several economic reports from the United States, Eurozone and Japan raised investors' concerns about an impending global economic slowdown.
Dow 30 Stock Roundup: WMT Earnings Beat, MRK's Keytruda sBLA Gets Priority Review
by Swarup Gupta
The index endured a holiday-shortened but volatile week.
CVS Health Stock Pops Before Q4 Earnings: What to Expect
by Benjamin Rains
Let's see what to expect from CVS' fourth-quarter financial results that are due out before the opening bell Wednesday.
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $72.11, marking a -0.44% move from the previous day.
What to Expect from CVS Health's Q4 Earnings, Revenue & Comps
by Benjamin Rains
Shares of CVS Health (CVS) have popped 4% in the last month and jumped 1.16% during regular trading Wednesday. But does this signal that investors expect good things from the pharmacy power's Q4 financial results that are due out before the opening bell on February 20?
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $70.12, moving -1.52% from the previous trading session.
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $71.88, moving -0.53% from the previous trading session.
Microsoft a Must Buy Ahead of Q2 Earnings
by Tirthankar Chakraborty
Addition of cloud computing is expected to help Microsoft continue its impressive record with respect to beating earnings estimates.
Can Rite Aid's (RAD) Reverse Stock Split Plan Aid Stock?
by Zacks Equity Research
Rite Aid (RAD) plans a reverse stock split to lift the stock price and regain compliance under NYSE listing rules.
Alphabet ECG Feature OK'd by FDA, Healthcare Plans on Track
by Zacks Equity Research
Alphabet's (GOOGL) Verily scores FDA clearance for its electrocardiogram technology (ECG) in its Study Watch.
Walgreens (WBA) Up 4.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Walgreens (WBA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $72.30, moving +0.43% from the previous trading session.
Dow 30 Stock Roundup: JPM & AXP Earnings Disappoint, GS & UNH Impress
by Swarup Gupta
The index enjoyed another strong week of gains, increasing over three straight sessions.
Microsoft, WBA Deal to Break AMZN, GOOGL Healthcare Dreams
by Zacks Equity Research
Microsoft (MSFT) inks a seven-year deal with Walgreens to offer innovative healthcare delivery solutions that can pose threat to Amazon and Google's growing presence.
Amazon Fear Grips Retail Pharmacy Space, Alliances Continue
by Urmimala Biswas
While Amazon is figuring out ways to expand in the multibillion dollar pharmacy industry, Walgreens and other industry players are ready to counter competition.
Bull of the Day: Lululemon (LULU)
by Benjamin Rains
This sportswear firm just raised its Q4 guidance and looks poised for success in a growing athleisure market.
Economic Data Deluge
by Zacks Equity Research
Economic Data Deluge
PPI Joins Q4 Reports for JPM, WFC & More; Big Day for Data
by Mark Vickery
Currently, Q4 earnings season is heating up in earnest, with two top Wall Street banks and two other sector leaders bringing results ahead of the opening bell.
Lululemon (LULU) Stock Looks Like a Buy & It Just Raised Its Q4 Guidance
by Benjamin Rains
Shares of Lululemon (LULU) soared as high as 8% in morning trading Monday after the yoga apparel powerhouse raised its Q4 earnings and revenue guidance.
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $71.71 in the latest trading session, marking a -1.06% move from the prior day.